Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Jin Medical International Ltd.
Jin Medical International Ltd. filed a SCHEDULE 13D/A regarding a change in beneficial ownership by major shareholder Wang Erqi. This filing serves to update the status of the shareholder's equity position and formalize changes related to the company's ownership structure.…more
Jin Medical International Ltd.
Jin Medical International completed the acquisition of Huaxia Qiying on September 24, 2026, for a total consideration of $159,415,729. The company issued 79,762,048 new Class A ordinary shares for the acquisition and financial advisory services, bringing the total outstanding shares to 158,194,533. Through this transaction, the company secured contractual control and the right to receive economic benefits from the target entity.…more
Jin Medical International Ltd.
Jin Medical International (ZJYL) has entered into a VIE control acquisition agreement to acquire Huaxia Qiying, a company holding ginseng-related assets and technology platforms, for an aggregate consideration of US$159,415,729. The company will issue 71,282,488 Class A ordinary shares as consideration, with an additional 8,479,560 shares to be issued as financial advisory fees.…more
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Jin Medical Shares Surge on $159M Acquisition Announcement
Jin Medical shares jumped after-hours following the announcement of its acquisition of Huaxia Qiying Technology. The deal involves significant share issuance, raising concerns regarding potential shareholder dilution.…more
●●●●●●●● ●●●●● ●●●●●●
Jin Medical International announced it will obtain contractual control and economic benefits of Huaxia Qiying through VIE agreements. The integrated transaction is valued at a total consideration of $159.4 million.…more
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.